Published online Nov 15, 2026. doi: 10.4251/wjgo.124574
Revised: August 2, 2026
Accepted: September 4, 2026
Published online: November 15, 2026
Processing time: 140 Days and 0.6 Hours
Calcifying fibrous tumor (CFT) is a rare benign neoplasm that uncommonly invo
A 69-year-old patient with dysphagia was found to have an esophageal mass on computed tomography. Gastroscopy identified a submucosal tumor (21-24 cm from the incisors) and an adjacent mucosal lesion (24-26 cm). Biopsy of the mucosal lesion revealed high-grade intraepithelial neoplasia. The submucosal tumor was excised via submucosal tunneling endoscopic resection (STER), and the mucosal lesion was resected by endoscopic submucosal dissection (ESD) in the same procedure. Pathological examination confirmed the diagnosis of CFT and moderately differentiated ESCC (1.5 cm × 1.6 cm), with submucosal invasion to a depth of 1000 μm, negative surgical margins, and no evidence of lymphovascular or perineural invasion. Additional therapy was advised but declined by the patient. Telephone follow-up at 3, 6, and 12 months postoperatively reported no symptomatic complaints; however, no objective endoscopic or imaging surveil
The combination of STER and ESD is technically achievable for synchronous esophageal lesions; nevertheless, its endorsement as a standard therapeutic option is precluded by the limitations inherent to a single case with incomplete post-procedural surveillance.
Core Tip: We present a case of synchronous esophageal calcifying fibrous tumor and esophageal squamous cell carcinoma in a 69-year-old man. The lesions were effectively treated in a single session using combined submucosal tunneling endoscopic resection and endoscopic submucosal dissection. This case underscores the technical viability of this combined strategy, highlights the diagnostic ambiguity of type B2 intrapapillary capillary loop changes in preoperative depth assessment, and emphasizes the necessity of rigorous postoperative surveillance to ensure oncological safety.
- Citation: Zhou Y, Duan H, Chen ZY, He DX. Endoscopic treatment of calcifying fibrous tumor of the esophagus combined with esophageal cancer: A case report. World J Gastrointest Oncol 2026; 18(11): 124574
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/124574.htm
- DOI: https://dx.doi.org/10.4251/wjgo.124574
Calcifying fibrous tumor (CFT) is a rare benign neoplasm initially documented by Rosenthal and Abdul-Karim[1] and formally designated by the World Health Organization in 2002. Although it may arise at various anatomical sites, the stomach is one of the most common locations. However, CFT of the esophagus is exceptionally uncommon and is typically discovered incidentally during examinations. Its indolent and nonspecific clinical features render its recognition particularly challenging. For superficial esophageal lesions, a multimodal endoscopic approach incorporating image-enhanced endoscopy and endoscopic ultrasound may facilitate more accurate preoperative evaluation[2-4]. In even rarer scenarios, when CFT coexists with esophageal carcinoma at an adjacent site, the principal therapeutic challenges include minimizing procedural morbidity and preoperatively estimating the depth of invasion of type B2 vascular lesions while achieving definitive treatment of both lesions. Herein, we describe a case in which a CFT exceeding 4 cm in length and an approximately 2 cm esophageal squamous neoplastic lesion were successfully resected during the same endoscopic procedure via combined submucosal tunneling endoscopic resection (STER) and endoscopic submucosal dissection (ESD). This combined strategy preserves the structural integrity of the esophagus and may offer valuable experience for ma
A 69-year-old male patient was referred to our hospital with a chief complaint of dysphagia.
The patient was initially admitted to the Department of Urology of our hospital on December 4, 2023, due to dysuria. During the clinical course, he reported dysphagia, and contrast-enhanced chest computed tomography (CT) revealed an esophageal mass. On December 15, 2023, gastroscopy identified a longitudinal elevated lesion in the upper esophagus, approximately 21-26 cm from the incisors. As shown in Figure 1, the proximal segment (21-24 cm) displayed a smooth submucosal tumor-like elevation (Figure 1A), whereas the distal portion at 24-26 cm showed a superficially elevated mucosal lesion with central erythema and slight depression, consistent with a 0-IIa lesion (Figure 1B). Under white-light endoscopy, the lesion exhibited a well-demarcated border, without obvious ulceration or nodular changes, and the distal end was covered with whitish exudate. A preoperative biopsy obtained at 24 cm from the incisors revealed high-grade intraepithelial neoplasia of the esophageal squamous epithelium. Accordingly, the patient was referred to the De
The patient had no notable past medical history.
No remarkable personal or family history was recorded.
Initial physical examination revealed no obvious abnormalities.
Laboratory tests performed on December 27, 2023, including tumor markers, immune function, coagulation, bioche
Contrast-enhanced chest CT demonstrated a nodular soft-tissue density lesion in the upper thoracic esophagus, pro
Magnifying narrow-band imaging (NBI) of the distal reddish mucosal lesion demonstrated a clear demarcation line. The intrapapillary capillary loop (IPCL) pattern was predominantly type B1, with focal type B2 changes mainly at the distal end; no type B3 vessels or avascular areas were identified (Figure 1D). No obvious tatami sign was noted. Lugol iodine chromoendoscopy revealed an unstained area with a localized pink-color sign (Figure 1F).
Endoscopic ultrasonography with a 20 MHz mini-probe disclosed a fusiform, hypoechoic subepithelial lesion at approximately 21-24 cm from the incisors. The lesion was predominantly hypoechoic to anechoic and projected into the lumen. The distal margin was ill-defined, the mucosal layer appeared mildly thickened, and focal hyperechoic spots were visible within the submucosal layer. The lesion measured approximately 40 mm × 20 mm (Figure 1G).
A multidisciplinary team comprising specialists in radiology, thoracic surgery, medical oncology/radiotherapy, and anesthesiology convened to evaluate the feasibility of combined STER and ESD. The team weighed the risks and benefits of endoscopic vs surgical resection, the uncertainty of preoperative depth assessment attributable to focal type B2 IPCL changes, and the possible need for additional intervention should final pathology indicate non-curative resection. Following comprehensive evaluation and informed consent, combined STER and ESD in a single endoscopic session was planned. Following confirmation of pT1b-SM2 non-curative on final pathology, a repeat multidisciplinary evaluation advised adjuvant surgery or chemoradiotherapy, which the patient declined.
Postoperative pathology and immunohistochemical staining confirmed the diagnosis of esophageal CFT. The synchronous esophageal squamous cell carcinoma was confirmed as moderately differentiated, pT1b-SM2 (with a sub
Preoperative assessment indicated that the submucosal tumor could be managed either by endoscopic resection or surgery. Conventional ESD was not considered the preferred option for the submucosal tumor given its relatively deep origin and the attendant risks of esophageal perforation, difficult wound closure, and postoperative stenosis. For the mucosal lesion, magnifying NBI, Lugol iodine staining, endoscopic ultrasonography, and contrast-enhanced CT were all suggestive of a superficial esophageal squamous neoplastic lesion, with a predicted invasion depth of cT1a-MM or cT1b-SM1. However, given that focal type B2 IPCL changes may introduce uncertainty in depth estimation, deeper invasion such as cT1b-SM2 could not be entirely ruled out. The patient and his family were counseled that ESD represented an appropriate endoscopic option, but additional treatment might be warranted if final pathology demonstrated non-curative resection, defined as submucosal invasion exceeding 200 μm in depth, lymphovascular invasion, or a positive vertical margin.
The procedure was carried out under endotracheal intubation general anesthesia with an Olympus Q260J therapeutic gastroscope fitted with a transparent cap. Following irrigation and aspiration of the esophageal and gastric mucosa, the mucosal lesion at approximately 24-26 cm from the incisors was demarcated approximately 0.5 cm outside its periphery using a 4 mm needle-type incision knife (Figure 2A). A mixed solution of normal saline, methylene blue, and sodium hyaluronate was instilled into the submucosal layer at approximately 17 cm from the incisors. After satisfactory lifting was achieved, a longitudinal mucosal incision of approximately 2 cm was created along the esophageal axis to establish the tunnel entry. A short submucosal tunnel of approximately 3 cm was then fashioned (Figure 2B). Within the tunnel, a whitish tumor arising from the muscularis propria was visualized, and the tumor was completely enucleated and extracted using a snare (Figure 2C-E). No obvious injury to the muscularis propria, perforation, or damage to the over
Upon completion of STER, the mucosal lesion was re-evaluated. The tunnel entry was promptly closed with three clips to seal the submucosal tunnel. The proximal aspect of the mucosal lesion was slight elevation, and the lesion adequate lifting was achieved following submucosal injection along the outer margin of the markings. Subsequently, ESD was performed along the marking line, resulting in complete dissection of the mucosal lesion (Figure 2F and G). No apparent adhesion was noted at the lesion base. The wound surface was treated with hemostatic forceps, and the ESD mucosal defect was closed using four clips (Figure 2H). The total procedure time was 50 minutes. No intraprocedural adverse events such as major bleeding, perforation, subcutaneous emphysema, or injury to the overlying tunnel mucosa, were encountered. A nasogastric decompression tube was placed postoperatively.
Postoperatively, the patient was managed with acid-suppressive therapy, vital-sign monitoring, fluid resuscitation, and supportive care. Prophylactic antibiotics were not administered. No delayed hemorrhage, perforation, chest pain, or other postoperative events were observed. The gastrointestinal decompression tube was withdrawn 48 hours postoperatively, and oral feeding was reinitiated, starting with a semiliquid diet and progressively advancing. The patient was discharged one week after the procedure free of notable discomfort.
Postoperative pathological findings confirmed the submucosal tumor as a CFT (Figure 3). Immunohistochemical staining showed the tumor cells to be negative for cluster of differentiation (CD) 117, desmin, CD34, smooth muscle actin (SMA), S-100, and DOG1, with a Ki-67 proliferation index of less than 1%. The definitive pathological assessment of the mucosal lesion revealed moderately differentiated esophageal squamous cell carcinoma, with dimensions of approximately 1.5 cm × 1.6 cm (Figure 3). The tumor demonstrated invasion into the submucosal layer to a depth of about 1000 μm. No lym
The patient was scheduled for outpatient follow-up at 3 months post-endoscopic treatment, and was also advised to undergo repeat gastroscopy and contrast-enhanced chest CT at 6 months. However, he failed to attend for the 3-month outpatient follow-up. At 6 months, telephone visit was conducted, during which repeat gastroscopy and imaging studies were again recommended. The patient reported no dysphagia, chest pain, hematemesis, melena, weight loss, or other symptoms, but declined repeat gastroscopy. At 12 months, telephone follow-up again revealed no dysphagia or related symptoms; however, the patient again refused gastroscopy. Consequently, this case lacks objective endoscopic and imaging follow-up data, and local recurrence or metastasis could not be accurately assessed.
CFT is a rare benign tumor initially described in the deep soft tissues of children by Rosenthal and Abdul-Karim[1]. Subsequent investigations have demonstrated that the lesion may also arise in adults. In 2002, the World Health Orga
| Ref. | n | Age/sex | Location/size | Presentation | Treatment/follow-up | Synchronous ESCC | Pathological features | Immunophenotype |
| Lee et al[6] | 1 | 54/F | Distal esophagus, 1 cm above the esophagogastric junction; 4 cm | Foreign body sensation/intermittent dysphagia | Local surgical excision; no recurrence at 1 year | Not reported | Abundant collagen, calcification, lymphoplasmacytic infiltration | CD32 (-), CD117 (-), S-100 (-), desmin (-) |
| Jahanbin et al[7] | 1 | 23/F | Cervical esophagus; 5 cm | Dysphagia; discovered during surgery for myasthenia gravis | Local surgical excision; no recurrence at 21 months | Not reported | Hyalinized collagen fibers, lympho-plasmacytic infiltration, psammomatous/dystrophic calcifications | ALK (-), CD34 (focally weakly +) |
| Liu et al[8] | 1 | 37/F | Cervical esophagus; 33 mm × 30 mm × 20 mm on pathology | Foreign body sensation; initially misdiagnosed as thyroid nodule | Local surgical excision; no recurrence at 2 years | Not reported | Dense collagen fibers, focal calcification, lymphocytic infiltration | Vimentin (+), SMA (+), desmin (-), CD34 (-), CD99 (-), STAT6 (-) |
| Sulaiman et al[9] | 1 | 67/M | Upper thoracic esophagus, 20 cm from the incisors; 1.3 mm × 0.8 mm × 0.6 cm | Intermittent dysphagia to liquids; foreign body sensation | Endoscopic mucosal resection; no recurrence at 6 months | Not reported | Abundant hyalinized collagen, spindle cells, lymphoplasmacytic infiltrates, widespread dystrophic calcifications | FXIIIa (+), ALK-1 (-), CD117 (-), desmin |
| Present case | 1 | 69/M | Upper esophagus, 21-24 cm from the incisors; approximately 4 cm/40 mm × 20 mm on EUS | Dysphagia; detected during evaluation after chest CT | STER combined with ESD in the same session; no objective endoscopic or imaging follow-up; symptom-based telephone follow-up only | Yes; adjacent moderately differentiated ESCC | Dense collagenous stroma with multiple calcifications, paucicellular bland spindle cells, lymphoplasmacytic infiltration, and chondroid-like hyalinized stroma; no cytologic atypia or increased mitotic activity | CD34 (-), SMA (-), desmin (-), S-100 (-), CD117 (-), DOG1 (-), Ki-67 (< 1%) |
Histologically, CFT is characterized by dense collagen fibers, scattered spindle cells, and blood vessels accompanied by variable lymphocytic and plasma cell infiltration, which may occasionally form lymphoid nodules or follicles with gritty bodies or calcifications[5]. To date, no definitive immunohistochemical marker for CFT has been established. In the majority of CFT cases, CD34 exhibits positivity, whereas SMA, CD117, S-100, and anaplastic lymphoma kinase are typi
Gastrointestinal CFTs need to be differentiated from mesenchymal and smooth muscle neoplasms, which typically show immunopositivity for CD117, CD34, and DOG1, and harbor mutations in the c-KIT and PDGFRa genes.
Local surgical resection is the treatment of choice for CFT, which has been shown to result in fewer cases of recurrence or metastasis. The development of endoscopic techniques enables the resection of most gastrointestinal CFTs via endoscopy, conferring a favorable prognosis[17,18]. To date, no documented fatalities have been associated with CFT.
In addition to STER, endoscopic submucosal excavation (ESE), endoscopic full-thickness resection (EFTR), and mucosal zipper endoscopic resection (MZER) are also available for the endoscopic management of selected esophageal submucosal tumors[10,19,20]. Per the Chinese consensus on endoscopic diagnosis and management of gastrointestinal submucosal tumors (version 2023), STER is recommended as the preferred treatment for esophageal submucosal tumors arising from the muscularis propria and measuring less than 3.5 cm[21]. Furthermore, tumors originating from the muscularis propria carry uncertainty with respect to deep infiltrative growth. If ESE is performed, when a muscularis propria defect occurs, postprocedural closure is relatively challenging and is associated with a higher risk of complications, such as infection or fistula. Additionally, this patient presented with a synchronous mucosal neoplastic lesion on the anal side of the submucosal tumor. Accordingly, following thorough multidisciplinary discussion and detailed informed consent obtained from the family concerning the surgical options and associated risks, a combined STER and ESD approach was adopted. Although EFTR is capable of achieving full-thickness resection, it results in a full-thickness esophageal wall defect and may increase the risk of wound closure difficulty, mediastinal infection, and fistula formation[10,19]. MZER exposes the tumor through incision of the overlying mucosa and then closes the incision in a zipper-like fashion with clips; however, evidence supporting this technique remains limited, and in cases of synchronous mucosal neoplasia, it may compromise complete resection of the mucosal lesion[20]. In contrast, STER enables removal of the submucosal tumor through a submucosal tunnel while preserving the integrity of the overlying mucosa to the greatest extent possible, thereby affording more stable procedural conditions for the subsequent ESD. Accordingly, in the present case, STER was performed initially to remove the CFT, followed by ESD for the adjacent squamous neoplastic lesion.
Given that this case involved a synchronous esophageal mucosal lesion, preoperative evaluation of the invasion depth of the squamous neoplastic lesion was critical for guiding the treatment strategy. Magnifying NBI revealed a clear demarcation line (DL-positive). The IPCL pattern was predominantly type B1, with scattered type B2 changes, and no type B3 vessels or avascular area were identified. Lugol iodine staining demonstrated an unstained area with a localized pink color sign. These findings were suggestive of a superficial esophageal squamous neoplastic lesion, and the preoperative invasion depth was thus considered likely to be cT1a-MM or cT1b-SM1[22,23], supporting the preoperative indication for ESD. However, type B2 IPCL changes carry some overlap and uncertainty in invasion depth prediction, and the actual depth may remain underestimated[22]. While preoperative magnifying endoscopy did not identify high-risk features of invasion, the final depth of invasion in this case measured 1000 μm, which corroborates well with the grey zone of type B2 IPCL changes and constitutes the most common limitation of endoscopic preoperative staging. A retro
This report presents an unusual case of esophageal CFT associated with synchronous esophageal squamous cell carcinoma. For complex esophageal lesions involving both a submucosal tumor and an adjacent mucosal neoplastic lesion, combined STER and ESD may enable single-session endoscopic management while preserving the integrity of the esophageal wall, indicating that this combined approach is technically feasible in selected complex cases. However, pathological evaluation of the resected specimen in this case demonstrated that the squamous cell carcinoma had invaded the submucosal layer to a depth of approximately 1000 μm. While the resection margins were negative and no lymph
| 1. | Rosenthal NS, Abdul-Karim FW. Childhood fibrous tumor with psammoma bodies. Clinicopathologic features in two cases. Arch Pathol Lab Med. 1988;112:798-800. [PubMed] |
| 2. | Chang LJ, Lee KH, Mukundan A, Karmakar R, Bauravindah A, Chen TH, Huang CW, Wang HC. Investigating object detection errors in endoscopic imaging of esophageal SCC and dysplasia through precision-recall analysis. Front Oncol. 2025;15:1707854. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 1] [Reference Citation Analysis (2)] |
| 3. | Koh KY, Mukundan A, Karmakar R, Atulbhai CT, Chen TH, Weng WC, Wang HC. Efficacy of Spectral-Aided Visual Enhancer in Classification of Esophageal Cancer. Cancers (Basel). 2026;18:1609. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 4. | Tsai YY, Lee KH, Mukundan A, Karmakar R, Nagisetti Y, Seyoum DG, Naing SL, Huang CW, Wang HC. Enhancing esophageal cancer detection using a deep learning framework and a novel spectrum-aided vision enhancer for virtual narrow band imaging. Sci Rep. 2026;16:25149. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 5. | Chorti A, Papavramidis TS, Michalopoulos A. Calcifying Fibrous Tumor: Review of 157 Patients Reported in International Literature. Medicine (Baltimore). 2016;95:e3690. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 96] [Cited by in RCA: 74] [Article Influence: 7.4] [Reference Citation Analysis (3)] |
| 6. | Lee SW, Yeh HZ, Chang CS. Calcifying fibrous pseudotumor of the esophagus. J Chin Med Assoc. 2010;73:599-601. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 6] [Cited by in RCA: 6] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
| 7. | Jahanbin B, Saffar H, Nazar E, Nili F. Calcifying fibrous tumor of the esophagus in a myasthenia gravis patient. Indian J Pathol Oncol. 2017;4:348-350. [DOI] [Full Text] |
| 8. | Liu Y, Lu Q, Wu XL, Shen GJ, Luo T. Ultrasonographic imaging of calcifying fibrous tumor of cervical esophagus: A case report. Medicine (Baltimore). 2019;98:e16425. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 6] [Cited by in RCA: 5] [Article Influence: 0.7] [Reference Citation Analysis (1)] |
| 9. | Sulaiman AA, Monroe HL, Olevian DC, El Jabbour T. Calcifying fibrous tumor of the esophagus: A case report with review of the pertinent literature. Human Pathol Rep. 2023;32:300704. [DOI] [Full Text] |
| 10. | Geng ZH, Zhu Y, Fu PY, Qu YF, Chen SY, Zhong YS, Zhang YQ, Chen WF, Qin WZ, Hu JW, Cai MY, Yao LQ, Li QL, Zhou PH. Endoscopic resection for calcifying fibrous tumors of the gastrointestinal tract. World J Clin Oncol. 2024;15:282-289. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 4] [Reference Citation Analysis (0)] |
| 11. | Tsai MK, Chen HY, Chuang ML, Chen CW, Jong GP. Gastric Calcifying Fibrous Tumor: An Easy Misdiagnosis as Gastrointestinal Stromal Tumor-A Systemic Review. Medicina (Kaunas). 2020;56:541. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 10] [Cited by in RCA: 11] [Article Influence: 1.8] [Reference Citation Analysis (1)] |
| 12. | Shi Q, Xu MD, Chen T, Zhong YS, Zhou PH, Wu HF, Yao LQ. Endoscopic diagnosis and treatment of calcifying fibrous tumors. Turk J Gastroenterol. 2014;25 Suppl 1:153-156. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 6] [Cited by in RCA: 7] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
| 13. | Wang J, Ao W, Mao G, Jia Y, Xie Z, Gu C, Yang G. Gastric calcifying fibrous tumors: Computed tomography findings and clinical manifestations. Medicine (Baltimore). 2021;100:e23334. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 8] [Article Influence: 1.6] [Reference Citation Analysis (0)] |
| 14. | Weynand B, Draguet AP, Bernard P, Marbaix E, Galant C. Calcifying fibrous pseudotumour: first case report in the peritoneum with immunostaining for CD34. Histopathology. 1999;34:86-87. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 30] [Cited by in RCA: 29] [Article Influence: 1.1] [Reference Citation Analysis (0)] |
| 15. | Hill KA, Gonzalez-Crussi F, Chou PM. Calcifying fibrous pseudotumor versus inflammatory myofibroblastic tumor: a histological and immunohistochemical comparison. Mod Pathol. 2001;14:784-790. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 118] [Cited by in RCA: 79] [Article Influence: 3.2] [Reference Citation Analysis (1)] |
| 16. | Larson BK, Dhall D. Calcifying Fibrous Tumor of the Gastrointestinal Tract. Arch Pathol Lab Med. 2015;139:943-947. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 29] [Cited by in RCA: 27] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
| 17. | Ye L, Liang M, Bai S, Zhou X, Chen O, Hu B, Mou Y. Calcified fibrous tumor in the stomach: a rare case of gastric submucosal tumor treated with endoscopic submucosal excavation. Endoscopy. 2023;55:E1201-E1202. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 3] [Cited by in RCA: 4] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
| 18. | Ogasawara N, Izawa S, Mizuno M, Tanabe A, Ozeki T, Noda H, Takahashi E, Sasaki M, Yokoi T, Kasugai K. Gastric calcifying fibrous tumor removed by endoscopic submucosal dissection. World J Gastrointest Endosc. 2013;5:457-460. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 17] [Cited by in RCA: 16] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
| 19. | Alwatari Y, Ayalew D, Sevdalis AE, Scheese D, Vudatha V, Julliard W, Shah RD. Endoscopic resection techniques of benign esophageal tumors: literature review. Ann Esophagus. 2023;6:17-17. [DOI] [Full Text] |
| 20. | Luo Z, Yu J, Zhang H, Yang S, Li J, Liu J, Wang S. A novel technique for submucosal tumors in the esophagus: mucosal zipper endoscopic resection. Endoscopy. 2025;57:1112-1117. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 2] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
| 21. | Endoscopic Surgery Group; Chinese Society of Digestive Endoscopology; Chinese Medical Association; NOTES Group; Chinese Society of Digestive Endoscopology; Chinese Medical Association; Digestive Endoscopy Specialty Committee; Endoscopic Physicians Branch of Chinese Medical Doctor Association; Gastrointestinal Surgery Group; Chinese Society of Surgery; Chinese Medical Association. [Chinese consensus on endoscopic diagnosis and managment of gastrointestinal submucosal tumors (version 2023)]. Zhonghua Xiaohua Neijing Zazhi. 2023;40:253-263. [DOI] [Full Text] |
| 22. | Oyama T, Inoue H, Arima M, Momma K, Omori T, Ishihara R, Hirasawa D, Takeuchi M, Tomori A, Goda K. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14:105-112. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 278] [Cited by in RCA: 254] [Article Influence: 25.4] [Reference Citation Analysis (3)] |
| 23. | Ishihara R, Kanzaki H, Iishi H, Nagai K, Matsui F, Yamashina T, Matsuura N, Ito T, Fujii M, Yamamoto S, Hanaoka N, Takeuchi Y, Higashino K, Uedo N, Tatsuta M, Tomita Y, Ishiguro S. Pink-color sign in esophageal squamous neoplasia, and speculation regarding the underlying mechanism. World J Gastroenterol. 2013;19:4300-4308. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 31] [Cited by in RCA: 28] [Article Influence: 2.2] [Reference Citation Analysis (2)] |
| 24. | Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O, Pioche M, Vieth M, Weusten BLAM, van Hooft JE, Deprez PH, Dinis-Ribeiro M. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy. 2022;54:591-622. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 617] [Cited by in RCA: 634] [Article Influence: 158.5] [Reference Citation Analysis (4)] |